Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 6.

Robinson, J A; Tamborrini, M; Geib, N; Marrero-Nodarse, A; Jud, M; Hauser, J; Aho, C; Lamelas, A; Zuniga, A; Pluschke, G; Ghasparian, A (2015). A Synthetic Virus-Like Particle Streptococcal Vaccine Candidate Using B-Cell Epitopes from the Proline-Rich Region of Pneumococcal Surface Protein A. Vaccines, 3(4):850-874.

Robinson, J A; Ghasparian, A (2015). Viral Nanotechnology: Synthetic Virus-like Particles in Vaccine Design. In: Khudyakov, Y; Pumpens, P. Viral Nanotechnology. Boca Raton, Florida, USA: CRC Press Taylor & Francis Group, 487-498.

Sharma, R; Ghasparian, A; Robinson, J A; McCullough, K (2012). Synthetic virus-like particles target dendritic cell lipid rafts for rapid endocytosis primarily but not exclusively by macropinocytosis. PLoS ONE, 7(8):e43248.

Riedel, T; Ghasparian, A; Moehle, K; Rusert, P; Trkola, A; Robinson, J A (2011). Synthetic virus-like particles and conformationally constrained peptidomimetics in vaccine design. ChemBioChem, 12(18):2829-2836.

Ghasparian, A; Riedel, T; Koomullil, J; Moehle, K; Gorba, C; Svergun, D I; Perriman, A W; Mann, S; Tamborrini, M; Pluschke, G; Robinson, J A (2011). Engineered synthetic virus-like particles and their use in vaccine delivery. ChemBioChem, 12(1):100-109.

Perriman, A W; Williams, D S; Jackson, A J; Grillo, I; Koomullil, J M; Ghasparian, A; Robinson, J A; Mann, S (2010). Synthetic virus-like particles and hybrid constructs based on lipopeptide self-assembly. Small, 6(11):1191-1196.

This list was generated on Tue Sep 26 08:39:46 2017 CEST.